These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33439285)

  • 1. Comparison Between Currently Recommended Long-Term Medical Management of Coronary Artery Aneurysms After Kawasaki Disease and Actual Reported Management in the Last Two Decades.
    Osborne J; Friedman K; Runeckles K; Choueiter NF; Giglia TM; Dallaire F; Newburger JW; Low T; Mathew M; Mackie AS; Dahdah N; Yetman AT; Harahsheh AS; Raghuveer G; Norozi K; Burns JC; Jain S; Mondal T; Portman MA; Szmuszkovicz JR; Crean A; McCrindle BW;
    Pediatr Cardiol; 2021 Mar; 42(3):676-684. PubMed ID: 33439285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-Molecular-Weight Heparin vs Warfarin for Thromboprophylaxis in Children With Coronary Artery Aneurysms After Kawasaki Disease: A Pragmatic Registry Trial.
    Manlhiot C; Newburger JW; Low T; Dahdah N; Mackie AS; Raghuveer G; Giglia TM; Dallaire F; Mathew M; Runeckles K; Pahl E; Harahsheh AS; Norozi K; de Ferranti SD; Friedman K; Yetman AT; Kutty S; Mondal T; McCrindle BW;
    Can J Cardiol; 2020 Oct; 36(10):1598-1607. PubMed ID: 32621885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variation in Pharmacologic Management of Patients with Kawasaki Disease with Coronary Artery Aneurysms.
    Selamet Tierney ES; Runeckles K; Tremoulet AH; Dahdah N; Portman MA; Mackie AS; Harahsheh AS; Lang SM; Choueiter NF; Li JS; Manlhiot C; Low T; Mathew M; Friedman KG; Raghuveer G; Norozi K; Szmuszkovicz JR; McCrindle BW;
    J Pediatr; 2022 Jan; 240():164-170.e1. PubMed ID: 34474088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bleeding risk associated with combination thromboprophylaxis therapy is low for patients with coronary artery aneurysms after Kawasaki disease.
    Low T; Jegatheeswaran A; Devlin PJ; Chahal N; Brandão LR; McCrindle BW
    Int J Cardiol; 2020 Dec; 321():6-11. PubMed ID: 32697954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thromboprophylaxis in patients with coronary aneurysms caused by Kawasaki disease].
    Suda K
    Nihon Rinsho; 2014 Sep; 72(9):1659-63. PubMed ID: 25518419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric Thromboprophylaxis of Large Coronary Artery Aneurysm Using Rivaroxaban.
    Montanez N; Sexson Tejtel SK; Menon NM
    J Pediatr Hematol Oncol; 2023 Aug; 45(6):356-359. PubMed ID: 37314881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strict management of a pregnant patient with giant coronary artery aneurysm due to Kawasaki disease.
    Taniguchi K; Ono H; Sato A; Kinomoto S; Tagawa N; Umehara N; Kato H; Sago H
    Pediatr Int; 2015 Oct; 57(5):990-2. PubMed ID: 26171683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term anticoagulation in Kawasaki disease: Initial use of low molecular weight heparin is a viable option for patients with severe coronary artery abnormalities.
    Manlhiot C; Brandão LR; Somji Z; Chesney AL; MacDonald C; Gurofsky RC; Sabharwal T; Chahal N; McCrindle BW
    Pediatr Cardiol; 2010 Aug; 31(6):834-42. PubMed ID: 20431996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medium-Term Complications Associated With Coronary Artery Aneurysms After Kawasaki Disease: A Study From the International Kawasaki Disease Registry.
    McCrindle BW; Manlhiot C; Newburger JW; Harahsheh AS; Giglia TM; Dallaire F; Friedman K; Low T; Runeckles K; Mathew M; Mackie AS; Choueiter NF; Jone PN; Kutty S; Yetman AT; Raghuveer G; Pahl E; Norozi K; McHugh KE; Li JS; De Ferranti SD; Dahdah N;
    J Am Heart Assoc; 2020 Aug; 9(15):e016440. PubMed ID: 32750313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of coronary artery measurements between echocardiograms and cardiac CT in Kawasaki disease patients with aneurysms.
    Gellis L; Castellanos DA; Oduor R; Gauvreau K; Dionne A; Newburger J; Friedman KG
    J Cardiovasc Comput Tomogr; 2022; 16(1):43-50. PubMed ID: 34548269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longterm outcomes in patients with giant aneurysms secondary to Kawasaki disease.
    Levy DM; Silverman ED; Massicotte MP; McCrindle BW; Yeung RS
    J Rheumatol; 2005 May; 32(5):928-34. PubMed ID: 15868632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-thrombosis management of patients with Kawasaki disease: Results from an international survey.
    Dionne A; Dahdah N; Singh-Grewal D; Burgner DP; Newburger JW; de Ferranti SD
    Int J Cardiol; 2020 May; 307():154-158. PubMed ID: 31753581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Safety of warfarin therapy in children with coronary aneurysm due to Kawasaki disease].
    He XH; Zhu QL; Yuan YH; Long XD; Xia XH; Wang S; Hu C
    Zhonghua Er Ke Za Zhi; 2021 Feb; 59(2):95-100. PubMed ID: 33548954
    [No Abstract]   [Full Text] [Related]  

  • 14. Multicenter and retrospective case study of warfarin and aspirin combination therapy in patients with giant coronary aneurysms caused by Kawasaki disease.
    Suda K; Kudo Y; Higaki T; Nomura Y; Miura M; Matsumura M; Ayusawa M; Ogawa S; Matsuishi T
    Circ J; 2009 Jul; 73(7):1319-23. PubMed ID: 19436123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of treatment and management of Kawasaki coronary artery disease based on clinical severity classification].
    Liu F; Zhao L; Wu L; Liang X; Chu C; He L; Huang G
    Zhonghua Er Ke Za Zhi; 2015 Sep; 53(9):690-5. PubMed ID: 26757970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medium- or Higher-Dose Acetylsalicylic Acid for Acute Kawasaki Disease and Patient Outcomes.
    Kim GB; Yu JJ; Yoon KL; Jeong SI; Song YH; Han JW; Hong YM; Joo CU
    J Pediatr; 2017 May; 184():125-129.e1. PubMed ID: 28043685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression and Complications of z-score-Based Giant Aneurysms in a Dutch Cohort of Kawasaki Disease Patients.
    Dietz SM; Kuipers IM; Koole JCD; Breur JMPJ; Fejzic Z; Frerich S; Dalinghaus M; Roest AAW; Hutten BA; Kuijpers TW
    Pediatr Cardiol; 2017 Apr; 38(4):833-839. PubMed ID: 28236162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Giant coronary aneurysms in infants with Kawasaki disease].
    Sánchez Andrés A; Salvador Mercader I; Seller Moya J; Carrasco Moreno JI
    An Pediatr (Barc); 2017 Aug; 87(2):65-72. PubMed ID: 27649630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term management of Kawasaki disease: implications for the adult patient.
    Manlhiot C; Niedra E; McCrindle BW
    Pediatr Neonatol; 2013 Feb; 54(1):12-21. PubMed ID: 23445738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Myocardial Infarction in Children with Giant Coronary Artery Aneurysms after Kawasaki Disease.
    Burns JC; El-Said H; Tremoulet AH; Friedman K; Gordon JB; Newburger JW
    J Pediatr; 2020 Jun; 221():230-234. PubMed ID: 32312552
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.